Abstract:Xinyi Shen, 1, 2 Ge Guo, 1, 2 Guoquan Feng, 3 Zhongqun Wang 1, 2 1 Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, People's Republic of China; 2 Institute of Cardiovascular Diseases, Jiangsu University, Zhenjiang, 212001, People's Republic of China; 3 Imaging Department, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, People's Republic of China Correspondence: Zhongqun Wang, Email Introduction: Vascular calcification is a major cause of cardiovascular accidents in patients with type 2 diabetes mellitus. This study aimed to investigate the impact of carbohydrates on gut microbiota and aortic calcification in diabetic ApoE −/− mice. Methods: The diabetic ApoE −/− mice were randomly divided into 4 groups: ketogenic diet group, low carbohydrate diet group, medium carbohydrate diet group, and high carbohydrate diet group. The mice were fed continuously for 6 months, with blood glucose, blood ketone and body weight monitored monthly. Lipid metabolism indicators and inflammatory factors were detected using ELISA. The intestinal barrier, atherosclerotic lesion areas, and vascular calcifications were analyzed based on their morphology. Gut microbiota was analyzed using 16S rRNA genes. Results: We found that ketogenic diet played some roles improving glucose, lipid metabolism, and inflammation. Ketogenic diet could improve the intestinal barrier to some extent and increase intestinal bacteria. Compared to the other three groups, the relative abundance of genus Allobaculum, species Blautia producta and Clostridium Ramosum in the ketogenic diet group was significantly increased ( P < 0.05), which has protective effects in diabetic ApoE −/− mice. Conclusion: Ketogenic diet could delay the onset of aortic atherosclerosis, aortic calcification and improve intestinal barrier function in diabetic ApoE −/− mice. Keywords: diabetes mellitus, atherosclerosis, vascular calcification, gut microbiota, low-carb diet, ketogenic diet, inflammation Graphical In 2021, an estimated 537 million adults globally had diabetes, with projections indicating a rise to 783 million by 2045. 1 Vascular calcification is a prevalent complication in diabetic patients and a major contributor to cardiovascular and cerebrovascular events. 2 The severity of vascular calcification is associated with an increased risk of cardiovascular incidents, stroke, and amputation in patients with type 2 diabetes mellitus (T2DM). 3 Despite its several adverse consequences, there are currently no effective treatments available to delay or prevent the development of vascular calcification. Therefore, there is an urgent need to develop new strategies for its prevention and treatment. The amount and type of dietary carbohydrates have long been controversial topics in the management of T2DM. Before the advent of insulin, most diabetes patients adopted a diet that strictly restricted carbohydrate intake and increased dietary fat intake. 4,5 With the recognition of cardiovascular complications in diabetes and the discovery of insulin, patients with T2DM have adopted a high-carbohydrate diet. 6 However, the prevalence of metabolic diseases has been gradually increasing, and adverse effects of high-carbohydrate diets, such as postprandial hyperglycemia, hyperinsulinemia, and lipid problems, have been reported. Accordingly, the American Diabetes Association recommended monitoring carbohydrate intake to control blood sugar. 7 A low-carbohydrate, high-fat diet has gradually become an approach for controlling weight and blood glucose in T2DM patients. 8 Therefore, this study was designed to investigate the long-term effects of different dietary carbohydrate levels on aortic calcification in diabetic mice. Studies have found significant differences in gut microbiota between healthy people and T2DM patients. However, in individuals with T2DM, there is a notable increase in Proteobacteria and Bacteroidetes, accompanied by a reduction in Firmicutes and a diminished Firmicutes/Bacteroidetes ratio. 9 Studies have demonstrated that, compared to healthy individuals, diabetic patients with cardiovascular complications exhibited significantly disrupted gut microbiota. Specifically, there is a marked reduction in the abundance of beneficial bacteria that are essential for maintaining normal intestinal immunity and metabolism, coupled with a significant increase in opportunistic pathogenic bacteria. 10,11 Diet plays a crucial role in modulating gut microbiota composition, which can subsequently im -Abstract Truncated-

Pravastatin promotes type 2 diabetes vascular calcification through activating intestinal Bacteroides fragilis to induce macrophage M1 polarization

The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in Coronary Artery Disease Patients with Type 2 Diabetes Mellitus: Rationale and Design of RosCal Study

Pravastatin up-regulates transforming growth factor-beta1 in THP-1 human macrophages: effect on scavenger receptor class A expression

Antibiotic-induced gut microbiota disruption promotes vascular calcification by reducing short-chain fatty acid acetate

Pravastatin prevents colitis-associated carcinogenesis by reducing CX3CR1high M2-like fibrocyte counts in the inflamed colon

Effects of Different Carbohydrate Content Diet on Gut Microbiota and Aortic Calcification in Diabetic Mice

Atorvastatin ameliorated myocardial fibrosis in db/db mice by inhibiting oxidative stress and modulating macrophage polarization

Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals

Gut-Flora-Dependent Metabolite Trimethylamine-N-Oxide Promotes Atherosclerosis-Associated Inflammation Responses by Indirect ROS Stimulation and Signaling Involving AMPK and SIRT1

Effects of Statin and Annatto-extracted Tocotrienol Supplementation on Glucose Homeostasis, Bone Microstructure, and Gut Microbiota Composition in Obese Mice

Simvastatin inhibits POVPC-mediated induction of endothelial-to-mesenchymal cell transition

Abstract 10391: Elevated Plasma Branched-Chain Amino Acids Level Promotes Atherosclerosis Progression by Facilitating Macrophage Polarization Toward M1 Phenotype That Results in the Increase of Inflammation

Branched-chain amino acids promote occurrence and development of cardiovascular disease dependent on triglyceride metabolism via activation of the mTOR/SREBP-1/betatrophin pathway

Atorvastatin Restores PPARα Inhibition of Lipid Metabolism Disorders by Downregulating miR-21 Expression to Improve Mitochondrial Function and Alleviate Diabetic Nephropathy Progression

Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study

Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome

Palmitic acid in type 2 diabetes mellitus promotes atherosclerotic plaque vulnerability via macrophage Dll4 signaling

Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia

Pravastatin Attenuates Atherosclerosis after Myocardial Infarction by Inhibiting Inflammatory Ly6Chigh Monocytosis in Apolipoprotein E Knockout Mice.

Autophagy reduces aortic calcification in diabetic mice by reducing matrix vesicle body-mediated IL-1β release

Enhancement of Autophagy by Simvastatin through Inhibition of Rac1‐mTOR Signaling Pathway